OOIR: Observatory of International Research

Papers

(The median citation count of American Journal of Respiratory and Critical Care Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome	1009
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline	797
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study	628
COVID-19 with Different Severities: A Multicenter Study of Clinical Features	594
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline	497
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline	496
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2	468
Characterization of the Inflammatory Response to Severe COVID-19 Illness	439
Why COVID-19 Silent Hypoxemia Is Baffling to Physicians	417
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease	402
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19	371
COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids	325
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study	318
Endothelial Responses in Sepsis	288
A Single-Cell Atlas of the Human Healthy Airways	279
COVID-19–associated Pulmonary Aspergillosis	267
Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2	260
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2	250
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis	232
Tissue-Specific Immunopathology in Fatal COVID-19	227
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations	225
Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study	217
Basing Respiratory Management of COVID-19 on Physiological Principles	204
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective	198
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline	195

Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis	194
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	190
Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium	189
Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study	185
High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19	175
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study	162
SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients	160
Lung- and Diaphragm-Protective Ventilation	158
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology	153
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome	151
Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study	150
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial	147
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele	147
Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome	142
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease	142
The Structural and Social Determinants of the Racial/Ethnic Disparities in the U.S. COVID-19 Pandemic. What’s Our Role?	137
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications	136
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease	136
Air Pollution, Genetic Factors, and the Risk of Lung Cancer: A Prospective Study in the UK Biobank	132
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline	128
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study	127
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection	126
Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids	124
Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU	124
Static and Dynamic Contributors to Ventilator-induced Lung Injury in Clinical Practice. Pressure, Energy, and Power	124
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline	124
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement	121
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal	120
From GOLD 0 to Pre-COPD	117
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	116
Respiratory Mechanics of COVID-19– versus Non–COVID-19–associated Acute Respiratory Distress Syndrome	113
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision	112
Effect of Lowering Vt on Mortality in Acute Respiratory Distress Syndrome Varies with Respiratory System Elastance	112
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical	112
Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery	110
Ineffectual Type 2–to–Type 1 Alveolar Epithelial Cell Differentiation in Idiopathic Pulmonary Fibrosis: Persistence of the KRT8^hi Transitional State	109
Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia	107
Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis	105
Sleep Apnea–Specific Hypoxic Burden, Symptom Subtypes, and Risk of Cardiovascular Events and All-Cause Mortality	104
Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data	103
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study	102
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules	102
Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs	102
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis	101
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency	99
Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia	99
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial	97
Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland	95
Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic	95
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension	93

New Physical, Mental, and Cognitive Problems 1 Year after ICU Admission: A Prospective Multicenter Study	90
The Early Change in Pa_CO₂after Extracorporeal Membrane Oxygenation Initiation Is Associated with Neurological Complications	90
Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19	90
The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal	88
The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality	88
Sleep Apnea and COVID-19 Mortality and Hospitalization	88
Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia	88
High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19	87
Airway Occlusion Pressure As an Estimate of Respiratory Drive and Inspiratory Effort during Assisted Ventilation	86
ACE2 Elevation in Severe COVID-19	85
Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease	85
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled T	84
Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells	83
Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline	82
Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study	82
Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis	82
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial	79
Changes to Visitation Policies and Communication Practices in Michigan ICUs during the COVID-19 Pandemic	78
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial	78
Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic	78
Natural History of Cognitive Impairment in Critical Illness Survivors. A Systematic Review	77
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles	76
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis	74
Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial	72
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward	72
Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?	71
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes	71
Ventilator Sharing during an Acute Shortage Caused by the COVID-19 Pandemic	71
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers	71
Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea	71
Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials	70
Air Pollution as a Risk Factor for Incident Chronic Obstructive Pulmonary Disease and Asthma. A 15-Year Population-based Cohort Study	70
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease	70
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline	70
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances	69
Bronchoscopy in Patients with COVID-19 with Invasive Mechanical Ventilation: A Single-Center Experience	69
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial	69
Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19–associated Acute Respiratory Distress Syndrome	68
High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19	68
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study	68
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial	67
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease	67
Latent Tuberculosis: Two Centuries of Confusion	67
Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models	66
Respiratory and Cardiovascular Outcomes in Survivors of Extremely Preterm Birth at 19 Years	66
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures	65
A Case of COVID-19 and Pneumocystis jirovecii Coinfection	65
Pulmonary Vascular Dilatation Detected by Automated Transcranial Doppler in COVID-19 Pneumonia	64
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study	63
Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell	63
Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome	63
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial	62
Home Nitric Oxide Therapy for COVID-19	62
Effect of Positive End-Expiratory Pressure and Proning on Ventilation and Perfusion in COVID-19 Acute Respiratory Distress Syndrome	62
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations	62
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial	62
Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults	62
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis	62
YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1	61
Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data	60
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial	60
Endotypic Mechanisms of Successful Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea	60
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease	60
Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL	60
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial	59
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review	59
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease	58
Prone Positioning of Nonintubated Patients with COVID-19	58
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists	57
Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon	57
TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis	57
Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis	57
Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study	56
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia	56
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19	56
Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19–related Acute Respiratory Distress Syndrome	55
Opioid Use Increases the Risk of Delirium in Critically Ill Adults Independently of Pain	55
Sustained Coinfections withStaphylococcus aureusandPseudomonas aeruginosain Cystic Fibrosis	55
Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to Streptococcus pneumoniae	55
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement	54

What Is Asthma?	54
Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial	54
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement	53
Diagnosis and Management of COVID-19 Disease	53
Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality	53
Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis	53
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19–related Acute Respiratory Distress Syndrome: Worth the Effort?	53
Extracorporeal Membrane Oxygenation for COVID-19–associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study	53
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial	52
Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection	52
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients	52
Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease	52
Human Fetal Lungs Harbor a Microbiome Signature	51
Single-Session Bronchial Thermoplasty Guided by ¹²⁹Xe Magnetic Resonance Imaging. A Pilot Randomized Controlled Clinical Trial	50
The Effect of Sleep Apnea on Cardiovascular Events in Different Acute Coronary Syndrome Phenotypes	50
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease	50
A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma	49
Hyperoxia Injury in the Developing Lung Is Mediated by Mesenchymal Expression of Wnt5A	49
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles	49
Prone Position and Lung Ventilation and Perfusion Matching in Acute Respiratory Failure due to COVID-19	49
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment	49
Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study	49
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomiz	49
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial	49
Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients	48
The POOR Get POORer: A Hypothesis for the Pathogenesis of Ventilator-induced Lung Injury	47
Urinary Leukotriene E₄and Prostaglandin D₂Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study	47
Interventional Bronchoscopy	47
Effect of Esophageal Pressure–guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial	47
Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study	47
High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis	47
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled Trial	46
Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes	46
Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension	46
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19	46
Importance of Early COPD in Young Adults for Development of Clinical COPD. Findings from the Copenhagen General Population Study	45
COVID-19 and Public Interest in Face Mask Use	45
Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis	45
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury	45
Comparative Effectiveness of Protective Ventilation Strategies for Moderate and Severe Acute Respiratory Distress Syndrome. A Network Meta-Analysis	45
Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling	45
Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III	45
Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study	45
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment	44
Muscle Protein Synthesis after Protein Administration in Critical Illness	44
Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome	44
Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea	44
Radiology–Pathology Correlation Demonstrating Organizing Pneumonia in a Patient Who Recovered from COVID-19	44
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome	44
COVID-19– versus non–COVID-19–related Acute Respiratory Distress Syndrome: Differences and Similarities	44
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ	43
A Race-neutral Approach to the Interpretation of Lung Function Measurements	43
Tracheal Intubation in the Critically Ill. Where We Came from and Where We Should Go	43
Gender Differences in Authorship of Critical Care Literature	43
Localization of Macrophages in the Human Lung via Design-based Stereology	43
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome	43
Is Computed Tomography Airway Count Related to Asthma Severity and Airway Structure and Function?	43
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19	43
Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos	43
Positive End-Expiratory Pressure, Pleural Pressure, and Regional Compliance during Pronation. An Experimental Study	43
Effects of Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial	42
E-Cigarette or Vaping Product Use–associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report	42
Exposure to Violence, Psychosocial Stress, and Asthma	42
Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU	42
Long-Term Outcomes in ICU Patients with Delirium: A Population-based Cohort Study	42
Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case–Control Studies	42
Cigarette Smoking and COVID-19: A Complex Interaction	42
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis	42
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study	41
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness	41
PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock	41
rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia	41
Airway Sensory Nerve Density Is Increased in Chronic Cough	41
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial	40
Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study	40
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis	40
Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study	40
Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care. NHLBI Working Group Report	40
Circulating MicroRNAs and Treatment Response in Childhood Asthma	40
Serial Measurement of Cell-Cycle Arrest Biomarkers [TIMP-2] · [IGFBP7] and Risk for Progression to Death, Dialysis, or Severe Acute Kidney Injury in Patients with Septic Shock	40
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review	40
Impulse Dispersion of Aerosols during Singing and Speaking: A Potential COVID-19 Transmission Pathway	40
Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial	40
Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China	40
BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease	39
Prenatal, Early-Life, and Childhood Exposure to Air Pollution and Lung Function: The ALSPAC Cohort	39
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement	39
Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time	39
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma	39
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children	38
Imaging the Respiratory Transition at Birth: Unraveling the Complexities of the First Breaths of Life	38
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program	38
High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19	38
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension	38
Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study	38